CBIO Catalyst Biosciences Inc.

$31.08 -6.07%

546,058 Shares Traded
551,258 Average Volume (last 30 days)

as of February 16, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $715.33 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-116.28%
If Intiated One Month Ago, Shorts Have Realized a Return of:-119.18%
If Initiated Five Days ago, Shorts Have Realized a Return of:12.7%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.5%
Short Interest355.89 thousand
Float6.48 million
Short Ratio0.9
Market Cap$213.15 million
Market Maker ActivityDaily Short Volume


Catalyst Biosciences: The Next Acquisition Target? (SeekingAlpha)
Catalyst Biosciences (CBIO) On Phase 1/2 clinical trial evaluating subcutaneous administration of hemophilia B candidate CB 2679d/ISU304 - Slideshow (SeekingAlpha)
Your Daily Pharma Scoop: GW Pharmaceuticals Pullback, Seattle Genetics Announces Collaboration Agreement, Catalyst Reports Data (SeekingAlpha)
Premarket Losers as of 9:05 am (2/9/2018) (SeekingAlpha)
Phase 1/2 data on Catalyst Bio's hemophilia B candidate underwhelms investors, shares down 12% premarket (SeekingAlpha)
Biotech Forum Daily Digest For January 5th (SeekingAlpha)
Catalyst Bio launches Phase 2/3 study of hemophilia candidate marzeptacog alfa (SeekingAlpha)
Midday Gainers / Losers (SeekingAlpha)
Your Daily Pharma Scoop: Valeant Still Risky, Onconova Signs Agreement, Array Biopharma Announces Collaboration (SeekingAlpha)
Catalyst Bio up 13% on positive Phase 1/2 data on hemophilia B candidate (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 22.8%

Earnings Stats

PE Ratio -2.37
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $8.01
50 Day Moving Average $18.57
52 Week High $37
52 Week Low $3.11

Data provided for free by IEX. Questions? Read the FAQ